Two new treatments for Crohn's disease equally effective
Two new treatments for Crohn's disease showed roughly equal performance in a clinical trial, according to findings published in The Lancet.
Jul 18, 2022
1
78
Two new treatments for Crohn's disease showed roughly equal performance in a clinical trial, according to findings published in The Lancet.
Jul 18, 2022
1
78
Scientists from St. Jude Children's Research Hospital have shown that the innate immune sensor, ZBP1, and its associated inflammatory cell death pathway, PANoptosis, are major contributors to the negative effects of interferon ...
May 19, 2022
0
39
Brain fog, headaches, and insomnia are some of the neurological symptoms doctors have observed in COVID-19 patients. Neurological sequelae after a viral infection is not new—in fact, following the 1918 influenza pandemic, ...
May 18, 2022
0
120
A UCLA-led team of researchers studying the effect of the monoclonal antibody Leronlimab on long COVID-19 may have found a surprising clue to the baffling syndrome, one that contradicts their initial hypothesis. An abnormally ...
Apr 22, 2022
1
675
The vast majority of people infected with the Omicron variant of SARS-CoV-2 experience mild cold-like symptoms, moderate flu-like symptoms, or no symptoms at all, but the virus is so transmissible that it still spread deep ...
Mar 30, 2022
0
212
Researchers from Indiana University School of Medicine Department of Microbiology and Immunology are studying new ways to treat seasonal or intermittent asthma. Their findings were recently published in Science Immunology.
Mar 21, 2022
0
75
Metastatic cells occur in many forms of cancer. They originate in primary tumors and then break away and migrate. They travel through the tissues surrounding them, through blood vessels or lymphatic channels. Along the way, ...
Mar 8, 2022
0
117
CRISPR genome editing has served as a powerful tool for deleting or altering DNA sequences and studying the resulting effect. Now, researchers at Gladstone Institutes and UC San Francisco (UCSF) have co-opted the CRISPR-Cas9 ...
Feb 3, 2022
0
89
Researchers at the National Eye Institute (NEI) have identified, isolated, and characterized a unique population of B cells that tamps down the immune system, reducing chronic inflammation. Infusions of purified IL-27 regulatory ...
Dec 2, 2021
0
38
Mayo Clinic researchers have linked the T cell dysfunction seen in rheumatoid arthritis with a metabolic deficiency, reported in a new Nature Immunology publication.
Nov 22, 2021
1
85